Expansion of Worldwide Distribution Agreement with Philips

VICTORIA, B.C., April 29, 2003 - CardioComm Solutions Inc. (TSX-V:CCG) (the "Company", "CardioComm") is pleased to announce that Philips Medical Systems ("Philips"), a division of Royal Philips Electronics (NYSE:PHG, AEX:PHI), has chosen to expand upon its distribution agreement with the Company.

Philips is currently the exclusive worldwide distributor for CardioComm's Arrhythmia Management System and AutoAttendant that features the Philips proprietary EASI technology. CardioComm and Philips are now expanding this distribution arrangement to include non-exclusive worldwide distribution of CardioComm's newest "Lite" software solution for event monitoring and transtelephonic pacemaker follow up. As well, Philips will now market AutoAttendant as a product for sale in the United States .

"We are extremely pleased with the expansion of our relationship.  It became clear, very early on, that the initial agreement between our two companies was just the beginning.  The pairing of our specialized software solutions with Philips devices and extensive sales and marketing channels is proving to be an excellent combination." Stephen Martin , President & CEO of CardioComm said.

Both companies will be at NASPE ( North American Society of Pacing and Electrophysiology) Annual Scientific Sessions from May 14-17 in Washington .

About CardioComm Solutions Inc:

CardioComm's patented and proprietary technology is used in products for the recording, viewing, analyzing and storing of electrocardiograms (ECGs), for diagnosis and management of cardiac patients. CardioComm has achieved its technical goals of improved access and communication through the development of a real-time ECG viewer. CardioComm is the first company to provide a real-time means of viewing ECGs over a network (LAN, WAN or Internet). This tool enables ECGs to be viewed and controlled live, by physicians, over a global virtual healthcare network. This technology is marketed as Global ECG Management System (GEMS™ ) and GlobalCardio™. CardioComm's software products have been cleared for sale in the United States by the U.S. Food and Drug Administration. The Company has both ISO 9001 and EN 46001 certifications.

On behalf of the Board of Directors of CardioComm Solutions Inc.:

“Stephen Martin”

Stephen R. Martin, President & CEO

For investor information, please contact:

Stephen Martin
1-877-744-1122